Deal of the Week: Why Pharmaceutical Companies Face an Existential M&A Crisis – Bloomberg


Bloomberg
Deal of the Week: Why Pharmaceutical Companies Face an Existential M&A Crisis
Bloomberg
Sanofi and Boehringer Ingelheim agreed to a $25 billion dollar trade of big business units this week, the conclusion of a deal that first surfaced in December. Asset swaps, while complicated, could be an increasingly popular maneuver among

and moreĀ >>

Source: pharmaceutical – Google News

Sharing information is key – Pharmaceutical Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd